Diagnostics & Tools January 2019

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

• Transactions in the Diagnostics & Tools industry totaled fourteen mergers & acquisitions and eighteen financings during the month of January
• In terms of M&A, Life Science Tools was the most active this month, with 7 transactions; while in terms of financing, In Vivo Diagnostic and Life Science Tools were equally active, with 6 financings each
• Total disclosed M&A value was $1.3 billion, while financings totaled $308.2 million
• The largest disclosed M&A transaction this month was the $1.1 billion acquisition of Thermo Fisher Scientific’s Anatomic Pathology Business by Kohlberg Kravis Roberts and PHC Holdings, while the largest financing was $77 million raised by Sophia Genetics
• M&A and financings in the United States accounted for 79% and 61% of total transactions this month, up 57% and 22%, respectively
• M&A activity this month includes acquisitions by KKR, Qiagen, Beckman Coulter, Abcam, and ArcherDx